KemPharm, Inc. (KMPH) earnings
Quarterly and annual KMPH reports and results, each read against the price at its own news timestamp. Back to the KMPH overview →
2 measured KMPH earnings events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-K ZEVRA THERAPEUTICS, INC. For: Dec 31 | SEC filing · Form 10-K | — | — | |
| Form 10-Q ZEVRA THERAPEUTICS, INC. For: Sep 30 | SEC filing · Form 10-Q | — | — |
Keep exploring
More KMPH: analyst actions → · SEC filings → · KMPH overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Concert Pharmaceuticals, Inc. (CNCE) | 911 | 0.00% | 48% |
| TROVAGENE (TROV) | 906 | -0.52% | 40% |
| Nektar Therapeutics (NKTR) | 898 | +0.07% | 53% |
| Tandem Diabetes Care, Inc. (TNDM) | 895 | +0.13% | 57% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.